Wexham Park Hospital
Slough, London, SL2 4HL, United Kingdom
NCT Number: NCT01739959
The investigators examined the hypothesis that serum lactate is raised in early necrotizing fasciitis to a much greater extent than in other differential diagnoses, such as severe cellulitis, and therefore provides a diagnostic indicator.
Looking for future studies?
Notify MeAll sexes
Observational
Slough, London, SL2 4HL, United Kingdom
A prospective comparison of serum lactate levels at referral to the Plastic Surgery team to the 'gold standard' test of histology at initial surgical debridement, looking at 53 consecutive patients referred with suspected necrotizing fasciitis to a single surgeon at one institution between 2000 and 2010.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At referral to the Plastic Surgery Team
Serum lactate level at initial referral to the plastic surgery team, as measured by arterial blood gas analysis (calibrated point-of-care testing). Levels compared between the group with confirmed histological necrosis at initial surgical debridement, versus those with no evidence of necrosis (a composite of those who did not undergo surgery as they were judged not to have necrotizing fasciitis, and those who did undergo surgery, but whose histology did not show tissue necrosis).
National Health Service, United Kingdom
Other Gov
Raised Serum Lactate as a Marker of Necrotizing Fasciitis; a Consecutive Prospective Review.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00261807
Bacterial Infections, Bacterial Infections and Mycoses
Baltimore, Maryland, United States
View Trial DetailsNCT04091672
Cellulitis, Connective Tissue Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT02469857
Bacterial Infections, Bacterial Infections and Mycoses
Birmingham, Alabama, United States
View Trial DetailsNCT03147352
Bacterial Infections, Bacterial Infections and Mycoses
Copenhagen, Denmark
View Trial Details